ATE473009T1 - Hemmung der neurodegeneration - Google Patents
Hemmung der neurodegenerationInfo
- Publication number
- ATE473009T1 ATE473009T1 AT02739383T AT02739383T ATE473009T1 AT E473009 T1 ATE473009 T1 AT E473009T1 AT 02739383 T AT02739383 T AT 02739383T AT 02739383 T AT02739383 T AT 02739383T AT E473009 T1 ATE473009 T1 AT E473009T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- inhibiting neurodegeneration
- alzheimer
- inhibiting
- neurodegeneration
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000016273 neuron death Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000012301 transgenic model Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/872,968 US6770797B2 (en) | 2001-06-01 | 2001-06-01 | Non-Transgenic nonhuman model for Alzheimer's Disease using a AD7c-NTP nucleic acid |
PCT/US2002/016429 WO2002099036A2 (en) | 2001-06-01 | 2002-05-28 | Inhibition of neurodegeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE473009T1 true ATE473009T1 (de) | 2010-07-15 |
Family
ID=25360708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02739383T ATE473009T1 (de) | 2001-06-01 | 2002-05-28 | Hemmung der neurodegeneration |
Country Status (8)
Country | Link |
---|---|
US (2) | US6770797B2 (de) |
EP (1) | EP1414478B1 (de) |
JP (1) | JP2005516886A (de) |
AT (1) | ATE473009T1 (de) |
AU (1) | AU2002312033B2 (de) |
CA (1) | CA2448863C (de) |
DE (1) | DE60236939D1 (de) |
WO (1) | WO2002099036A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002089841A2 (en) * | 2001-05-04 | 2002-11-14 | Nymox Corporation | Method of preventing cell death using antibodies to neural thread proteins |
EP1503801A4 (de) * | 2002-04-26 | 2006-02-08 | Ian A Ferguson | Nichtinvasive abgabe von polypeptiden durch die blut-hirn-schranke und in-vivo-auswahl von endozytotischen liganden |
AU2003233120B2 (en) * | 2002-04-26 | 2008-08-21 | Ferguson, Ian Andrew | Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
EP2381774A4 (de) * | 2008-12-23 | 2012-07-18 | Salk Inst For Biological Studi | Verfahren zur behandlung von neurodegenerativen erkrankungen |
CN102822672B (zh) * | 2010-01-08 | 2015-12-09 | 安科健康公司 | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948634A (en) | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
CA2109955A1 (en) | 1991-05-24 | 1992-11-26 | Toru Hayakawa | Equipment for intracerebral administration of preparations |
DE69434844T2 (de) | 1993-04-20 | 2006-12-14 | The General Hospital Corp., Boston | Geneexpression der neurofilamentproteine und nachweis der alzheimeschen erkrankung |
US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
US5863898A (en) | 1996-10-29 | 1999-01-26 | Incyte Pharmaceuticals, Inc. | Human lim proteins |
JP3758792B2 (ja) | 1997-02-25 | 2006-03-22 | 三菱重工業株式会社 | ガスタービン動翼のプラットフォーム冷却機構 |
NZ337445A (en) | 1997-02-26 | 2000-12-22 | Gen Hospital Corp | Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
DE69838789T2 (de) | 1997-03-12 | 2008-10-30 | Suzanne Cambridge de la Monte | Verfahren zur behandlung oder prävention der alzheimerischen krankheit |
-
2001
- 2001-06-01 US US09/872,968 patent/US6770797B2/en not_active Expired - Lifetime
-
2002
- 2002-05-28 DE DE60236939T patent/DE60236939D1/de not_active Expired - Lifetime
- 2002-05-28 CA CA2448863A patent/CA2448863C/en not_active Expired - Fee Related
- 2002-05-28 AT AT02739383T patent/ATE473009T1/de not_active IP Right Cessation
- 2002-05-28 JP JP2003502146A patent/JP2005516886A/ja active Pending
- 2002-05-28 AU AU2002312033A patent/AU2002312033B2/en not_active Ceased
- 2002-05-28 WO PCT/US2002/016429 patent/WO2002099036A2/en active Application Filing
- 2002-05-28 EP EP02739383A patent/EP1414478B1/de not_active Expired - Lifetime
-
2004
- 2004-08-02 US US10/910,173 patent/US7319094B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2448863A1 (en) | 2002-12-12 |
EP1414478A2 (de) | 2004-05-06 |
WO2002099036A3 (en) | 2004-01-08 |
US20030050262A1 (en) | 2003-03-13 |
EP1414478A4 (de) | 2007-03-21 |
CA2448863C (en) | 2010-05-04 |
DE60236939D1 (de) | 2010-08-19 |
US6770797B2 (en) | 2004-08-03 |
US7319094B2 (en) | 2008-01-15 |
EP1414478B1 (de) | 2010-07-07 |
JP2005516886A (ja) | 2005-06-09 |
WO2002099036A2 (en) | 2002-12-12 |
AU2002312033B2 (en) | 2007-10-18 |
US20050090441A1 (en) | 2005-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04004714A (es) | Derivados de aril 1,4-pirazina sustituidos. | |
MY130489A (en) | Substituted aryl 1, 4-pyrazine derivatives | |
MX2007016136A (es) | Metodo para diagnosticar la enfermedad de alzheimer. | |
IL154794A0 (en) | Remedies for heart failure | |
AU2002232393A1 (en) | Methods for identifying genes associated with diseases or specific phenotypes | |
WO2005004814A3 (en) | Sirt1 and genetic disorders | |
EA200300027A1 (ru) | Способ лечения сердечно-сосудистых заболеваний | |
EP1743036A4 (de) | Mit dem alter bei erstauftreten von alzheimer im zusammenhang stehende apoe-genmarker | |
WO2001058476A3 (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
ATE473009T1 (de) | Hemmung der neurodegeneration | |
ATE541923T1 (de) | Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit | |
AU2002356998A8 (en) | Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers | |
WO2002004677A3 (en) | Methods for diagnosis and treatment of psychiatric disorders | |
DE60133466D1 (de) | Metallischer einsatzkörper, verfahren zur herstellung desselben und metallisches gussteil | |
ATE522230T1 (de) | Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit | |
WO2004006856A3 (en) | Iron sequestration or elimination to reduce neurodegeneration or parkinsons disease progression | |
TW200503717A (en) | Substituted 1,4-pyrazine derivatives | |
DE60323034D1 (de) | Form zur Herstellung von Modell und Modell zum Feingiessen | |
EP1688036A4 (de) | Transgenes nichthumanes säugetier | |
WO2005072241A3 (en) | Inhibition of bright function as a treatment for excessive immunoglobulin production | |
WO2002027034A3 (en) | Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents | |
SI1292187T1 (sl) | Transgenski zivalski model nevrodegenerativnih motenj | |
EP1678328A4 (de) | Mit dem alter beim ausbruch von morbus alzheimer assoziierte genetische ntrk1-marker | |
WO2006017386A3 (en) | Signaling intermediates in an in vitro model of alzheimer’s disease | |
DE60133563D1 (de) | Külen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |